- Trials with a EudraCT protocol (692)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
692 result(s) found for: Identification.
Displaying page 10 of 35.
| EudraCT Number: 2010-019759-23 | Sponsor Protocol Number: PET-CT140410 | Start Date*: 2011-01-12 | |||||||||||
| Sponsor Name:Guys' and St. Thomas' NHS Foundation Trust | |||||||||||||
| Full Title: Evaluation of [11C]-methionine positron emission computerised tomography (PET CT) in diagnosing neurofibromatosis 1(NF1) - malignant peripheral nerve sheath tumours (MPNST) | |||||||||||||
| Medical condition: The diagnosis of malignant peripheral nerve sheath tumours in patients with neurofibromatosis 1 | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-003648-31 | Sponsor Protocol Number: PKPDHM-001 | Start Date*: 2011-11-17 | |||||||||||
| Sponsor Name:Universitätsklinikum Erlangen | |||||||||||||
| Full Title: Pharmacokinetic-pharmacodynamic modeling of the postoperative pain sensation during patient-controlled analgesia with target-controlled infusion of Hydromorphone, taking into account the interactio... | |||||||||||||
| Medical condition: Pain therapy after elective cardiac surgery | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2012-002106-48 | Sponsor Protocol Number: BCF-2009.01 | Start Date*: 2012-07-06 |
| Sponsor Name:University College Dublin | ||
| Full Title: An Investigative Study to characterize gene expression patterns in myeloid cells that are triggered during acute asthma exacerbations, and to identify associated genes/gene networks that are Omaliz... | ||
| Medical condition: Asthma | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: IE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-001542-29 | Sponsor Protocol Number: 106260 | Start Date*: 2015-06-22 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: A phase IIIb, randomized, double-blind, placebo-controlled study to explore the existence of horizontal transmission of the RIX4414 vaccine strain between twins within a family. | ||
| Medical condition: Rotavirus (RV) gastroenteritis | ||
| Disease: | ||
| Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2005-004541-34 | Sponsor Protocol Number: 21092005 | Start Date*: 2006-02-14 |
| Sponsor Name:South Manchester University Healthcare Trust | ||
| Full Title: The Effect of Enteral Administration of Synbiotics Upon Infection Rates in Major Burns | ||
| Medical condition: Major burn injuries: Thermal related trauma with burn injury involving significant proportions of the total body surface area, as defined by age: Adults (>=17 years old): >= 15% body surface area ... | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-001842-19 | Sponsor Protocol Number: GINECO-CE103 | Start Date*: 2008-08-14 | |||||||||||
| Sponsor Name:ARCAGY | |||||||||||||
| Full Title: Etude de phase I / II de l’association carboplatine et topotecan oral hebdomadaire chez des patientes atteintes de cancer du col de l’utérus métastatique ou en rechute. | |||||||||||||
| Medical condition: ASSOCIATION CARBOPLATINE ET TOPOTECAN ORAL HEBDOMADAIRE CHEZ DES PATIENTES ATTEINTES DE CANCER DU COL DE L’UTERUS METASTATIQUE OU EN RECHUTE | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2007-005628-34 | Sponsor Protocol Number: P070145 | Start Date*: 2008-09-12 | |||||||||||
| Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
| Full Title: Etude de phase II d’identification de biomarqueurs de réponse au sunitinib chez des patients atteints d’une tumeur neuroendocrine peu différenciée avancée inopérable. | |||||||||||||
| Medical condition: Tumeurs Neuro-Endocrines (TNE) digestives | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-003516-31 | Sponsor Protocol Number: NEOPACHI-001 | Start Date*: 2012-11-29 |
| Sponsor Name:CUB Erasme Hospital | ||
| Full Title: Evaluation of tumoral perfusion modification by dynamic imaging after neoadjuvant chemotherapy combining gemcitabine and a Hedgehog inhibitor (Vismodegib) in patients with resectable pancreatic ade... | ||
| Medical condition: Potentially resectable pancreatic ductal adenocarcinoma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-013455-30 | Sponsor Protocol Number: AOBS-ECT-CH | Start Date*: 2009-12-15 | |||||||||||
| Sponsor Name:AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA | |||||||||||||
| Full Title: EFFICACY OF ELETTROPORATION COMBINED WITH BLEOMYCIN IN THE TREATMENT OF KELOIDS AND HYPERTROPHIC SCARS: A PILOT STUDY | |||||||||||||
| Medical condition: KELOIDS AND HYPERTROPHIC SCARS | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-019863-12 | Sponsor Protocol Number: Mouvements | Start Date*: Information not available in EudraCT |
| Sponsor Name:Paris Descartes - Laboratoire Psychologie Clinique et Psychopathologie | ||
| Full Title: Analyse du mouvement rythmique spontané, mesure de la cohérence cardiaque et appréciation des conduites cliniques et langagières chez des enfants hyperactifs en situation d'examen psychométrique et... | ||
| Medical condition: Motor control and activities régulation attention's capacities | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-023355-29 | Sponsor Protocol Number: PO1425 | Start Date*: 2011-05-18 | |||||||||||
| Sponsor Name:Papworth Hospital NHS Foundation Trust | |||||||||||||
| Full Title: Tyrosine kinase Inhibitors in DysplAsia of Lung epithelium Study 1 | |||||||||||||
| Medical condition: High grade dysplasia of the bronchoepithelium | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-001123-35 | Sponsor Protocol Number: IDI-ONC-2-20070220 | Start Date*: 2007-11-18 | |||||||||||
| Sponsor Name:ISTITUTO DERMOPATICO IMMACOLATA | |||||||||||||
| Full Title: PHASE II STUDY OF DOCETAXEL AND OXALIPLATIN ASSOCIATION AS I LINE THERAPY IN ADVANCED NON SMALL CELL LUNG CANCER (NSCLC) PATIENTS: SCHEDULE-DEPENDENT ACTIVITY AND MOLECULAR TARGETS EVALUATION | |||||||||||||
| Medical condition: NON SMALL CELL LUNG CANCER (NSCLC) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-002318-22 | Sponsor Protocol Number: CTBM100C2303 | Start Date*: 2009-09-07 | |||||||||||
| Sponsor Name:Novartis Pharma Services AG | |||||||||||||
| Full Title: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase III Study in Cystic Fibrosis (CF) Subjects to Assess Efficacy, Safety and Pharmacokinetics of Tobramycin Inhalation Powder from a ... | |||||||||||||
| Medical condition: Pseudomonas aeruginosa infection in cystic fibrosis patients | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: LT (Completed) LV (Completed) EE (Completed) BG (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-000581-58 | Sponsor Protocol Number: BioBioV4.0 | Start Date*: 2015-10-14 |
| Sponsor Name:Revmatologicky ustav Praha | ||
| Full Title: A Randomized, Biomarker Trial to Predict Therapeutic Responses of Patients with Rheumatoid Arthritis to a Specific Biologic Mode of Action | ||
| Medical condition: Rheumatoid Arthritis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: CZ (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-006453-40 | Sponsor Protocol Number: INFLTX08 | Start Date*: 2009-11-20 | |||||||||||
| Sponsor Name:Karolinska University hospital Huddinge | |||||||||||||
| Full Title: Peg-INF alfa-2a plus ribavirin treatment of liver transplant patients with hepatitis C relaps on protocol liver biopsies - a Nordic study on rapid viral response, early viral response, end of treat... | |||||||||||||
| Medical condition: Chronic hepatitis C infection | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2015-003042-47 | Sponsor Protocol Number: InsulaTOP | Start Date*: 2015-12-16 | |||||||||||
| Sponsor Name:Centre Hospitalier Henri Laborit | |||||||||||||
| Full Title: Psycho-biological substrates of therapeutic benefit of thermal cure on Generalized Anxiety Disorders | |||||||||||||
| Medical condition: Generalised Anxiety Disorders | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-003413-10 | Sponsor Protocol Number: ACDHUVV-16 | Start Date*: 2016-12-20 |
| Sponsor Name:FIMABIS | ||
| Full Title: MicroRNAs expression analysis in patients undergoing cardiac surgery treated with halogenated anesthetics. Identification of microRNAs related to the cardioprotective effect | ||
| Medical condition: Cardiac surgery | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-002147-10 | Sponsor Protocol Number: FLU-MARK | Start Date*: 2011-09-21 | ||||||||||||||||
| Sponsor Name:Institute for Biomedical Aging Research | ||||||||||||||||||
| Full Title: Influenza vaccination in old age: Immunological and biogerontological characterization of responders and non-responders | ||||||||||||||||||
| Medical condition: This study will analyze cellular and humoral immune responses after seasonal vaccination against influenza. Healthy adults are vaccinated with a licensed trivalent inactivated vaccine without adjuv... | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: AT (Prematurely Ended) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2009-014997-16 | Sponsor Protocol Number: MPASNP1 | Start Date*: 2010-04-08 | |||||||||||
| Sponsor Name:Medizinische Universität Wien, Abteilung für Nephrologie und Dialyse | |||||||||||||
| Full Title: Identification of patients with high probability of not or poorly responding to therapy with mycophenolic acid pro-drugs. | |||||||||||||
| Medical condition: Patients with a de novo kidney transplantation | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-004507-36 | Sponsor Protocol Number: CTBM100DDE01 | Start Date*: 2008-08-19 | |||||||||||
| Sponsor Name:Novartis Pharma GmbH | |||||||||||||
| Full Title: A multicenter, open label, 2 period cross-over study to evaluate the Pharmacokinetics of an 8 week continuous treatment with 1x300mg/d and 2x300mg/d TOBI® inhaled with the PARI eFlow® rapid in Cyst... | |||||||||||||
| Medical condition: patients with cystic fibrosis and chronical infection with Pseudomonas aeruginosa | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.